Weave Bio Raises $20M Series A Led by USVP

Deal Summary

Weave Bio, an AI-native regulatory automation management provider based in San Francisco, raised $20M in a Series A round led by USVP with participation from Innovation Endeavors, Magnetic Ventures, Character, TMV and Serrado Capital. The funding will be used to accelerate product development and expand the company's offerings.